Page last updated: 2024-10-24

carmustine and Chromosome-Defective Micronuclei

carmustine has been researched along with Chromosome-Defective Micronuclei in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morales-Ramírez, P1
Vallarino-Kelly, T1
Cruz-Vallejo, VL1
Ferguson, LR1
Hill, CL1
Morecombe, P1

Other Studies

2 other studies available for carmustine and Chromosome-Defective Micronuclei

ArticleYear
Effect of O6-chloroethylguanine DNA lesions on the kinetics and mechanism of micronucleus induction in vivo.
    Environmental and molecular mutagenesis, 2010, Volume: 51, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; DNA Damage; Dose-Response Relationship, Drug

2010
Induction of resistance to 6-thioguanine and cytarabine by a range of anticancer drugs in Chinese hamster AA8 cells.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5

    Topics: Amsacrine; Animals; Antineoplastic Agents; Bleomycin; Carmustine; CHO Cells; Clone Cells; Cricetinae

1992